Sanofi   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Paris France (1973)
Status: Acquired by Sanofi-Synthelabo (1999) → now Sanofi-Aventis (2004)

Organization Overview

First Clinical Trial
1993
NCT00452491
First Marketed Drug
1973
clomifene (clomid)
First NDA Approval
2017
sarilumab (kevzara)
Last Known Activity
2022

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Sanofi | SANOFI | Sanofi Genzyme | Sanofi KK | Sanofi K.K. | sanofi pasteur SA | Sanofi Topaz | SANOFI US